Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01211
|
|||||
Drug Name |
Nimodipine
|
|||||
Synonyms |
1,4-Dihydro-2,6-dimethyl-4-(3′-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl-1-methylethyl Ester; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester;1-methylethyl 2-(methyloxy)ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 2-Methoxyethyl-1-methylethyl ester; 2-methoxyethyl propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-methoxyethyl 1-methylethyl ester; 3,5-pyridinecarboxylic acid 2-methoxyethyl 1-methylethyl ester; 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl), 2-methoxyethyl 1-methylethyl ester; 3-(2-methoxyethyl) 5-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide; Admon; Almirall Brand of Nimodipine; Alpharma Brand of Nimodipine; Andromaco Brand of Nimodipine; Bay-E 9736; Bay-e-9736; Bayer Brand of Nimodipine; Bayvit Brand of Nimodipine; Brainal; Calnit; Cantabria Brand of Nimodipine; DRG-0139; EG-1961; Elan Brand of Nimodipine; Esteve Brand of Nimodipine; Hexal Brand of Nimodipine; Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; Kenesil; Modus; N-149; NIMOTOP (TN); NimoGel; Nimodipin Hexal; Nimodipin ISIS; Nimodipin-ISIS; NimodipinISIS; Nimodipine (USAN/INN); Nimodipine [USAN:BAN:INN]; Nimodipino; Nimodipino Bayvit; Nimodipino [INN-Spanish]; Nimodipinum; Nimodipinum [INN-Latin]; Nimotop; Nimotop (TN); Nimotop(TM); Nimotop, Nimodipine; Periplum; Periplum, Nimotop, BRN 0459792, DRG-0139; Remontal; Vita Brand of Nimodipine
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Cerebral vasospasm [ICD11: BA85.Z] | Approved | [1] | |||
Therapeutic Class |
Vasodilator Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C21H26N2O7
|
|||||
Canonical SMILES |
CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
|
|||||
InChI |
InChI=1S/C21H26N2O7/c1-12(2)30-21(25)18-14(4)22-13(3)17(20(24)29-10-9-28-5)19(18)15-7-6-8-16(11-15)23(26)27/h6-8,11-12,19,22H,9-10H2,1-5H3
|
|||||
InChIKey |
UIAGMCDKSXEBJQ-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 66085-59-4
|
|||||
Pharmaceutical Properties | Molecular Weight | 418.4 | Topological Polar Surface Area | 120 | ||
Heavy Atom Count | 30 | Rotatable Bond Count | 9 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 8 | |||
XLogP |
3.1
|
|||||
PubChem CID | ||||||
PubChem SID |
11119999
, 11120487
, 11120975
, 11121462
, 11121942
, 11147082
, 11341987
, 11362170
, 11362531
, 11364815
, 11365093
, 11367377
, 11367655
, 11369939
, 11370333
, 11370334
, 11371732
, 11373256
, 11374401
, 11375817
, 11378106
, 11466946
, 11468066
, 11485200
, 11486721
, 11487572
, 11489378
, 11490582
, 11492606
, 11495694
, 11528721
, 12013716
, 14831516
, 17405450
, 24277858
, 26612490
, 26663021
, 26680672
, 26747118
, 26747119
, 3153214
, 4444853
, 596563
, 6951262
, 7404101
, 7847504
, 7980128
, 8152770
, 855566
, 9476
|
|||||
ChEBI ID |
CHEBI:7575
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Nimodipine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.